ESOR Special Focus Series
Lung Cancer Screening - 1
Lectures
1
Lung Cancer Screening: The Korean Experience
30:00Jin Mo Goo
2
Willingness to Participate in Lung Cancer Screening: Key Motivational Factors
30:00Maarten Ijzerman
3
Screening as a Mindset: Moving Beyond Diagnostic Thinking
30:00Marjolein Heuvelmans
4
Defining who to screen: overview of the different approaches to lung cancer screening eligibility
30:00Joanna Chorostowska-Wynimko
5
The ESTI nodule management recommendations: focusing on nodule aggressiveness
30:00Helmut Prosch
6
Quality first: Implementing quality assurance in LCS programs
30:00Anna Kerpel-Fronius
7
Integrating Coronary Artery Calcium Scoring into Lung Cancer Screening: How and why
30:00Rozemarijn Vliegenthart
8
Case-Based Session #1
30:00Arjun Nair
COURSE INFORMATION
The Special Focus Series offers unique courses, tailored to address some of the most pressing topics for radiologists today.
The series includes both online and onsite courses, in a range of different formats.
From oncology and mental health to teaching skills and sustainability practices, the Special Focus Series aims to give you the skills modern radiologists need.
This advanced ESOR Special Course offers an in-depth exploration of lung cancer screening (LCS) across Europe and beyond. Through lectures by leading international experts, participants will gain a comprehensive understanding of current evidence, implementation strategies, and practical challenges in LCS. Combining scientific insight with real-world experience, the course equips radiologists with the tools to play an active role in screening programmes—enhancing early detection, patient communication, and multidisciplinary collaboration.
Attention: You need to attend both days to receive a CME certificate!
See here for more information.
LEARNING OBJECTIVES
-
Describe current eligibility criteria and international approaches to lung cancer screening.
-
Apply evidence-based strategies for nodule management and quality assurance in LCS.
-
Recognise additional thoracic and cardiovascular findings relevant to screening participants.
-
Evaluate the role and limitations of AI in lung cancer screening workflows.
-
Communicate screening results effectively and empathetically to participants.
PROGRAMME ONLINE
Monday, January 19, 2026
| 12:30 – 13:00 | Lung Cancer Screening: The Korean Experience Jin Mo Goo, Seoul/KR |
| 13:00 – 13:30 | Willingness to Participate in Lung Cancer Screening: Key Motivational Factors Maarten Ijzerman, Rotterdam/NL |
| 13:30 – 14:00 | Screening as a Mindset: Moving Beyond Diagnostic Thinking Marjolein Heuvelmans, Groningen/NL |
| 14:00 – 14:30 | Defining Who to Screen: Overview of the Different Approaches to Lung Cancer Screening Eligibility Joanna Chorostowska-Wynimko, Warsaw/PL |
| 14:30 – 15:00 | Q&A Session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:00 | The ESTI Nodule Management Recommendations: Focusing on Nodule Aggressiveness Helmut Prosch, Vienna/AT |
| 16:00 – 16:30 | Quality first: Implementing Quality Assurance in LCS Programmes Anna Kerpel-Fronius, Budapest/HU |
| 16:30 – 17:00 | Integrating Coronary Artery Calcium Scoring into Lung Cancer Screening: How and Why Rozemarijn Vliegenthart, Groningen/NL |
| 17:00 – 17:30 | Case-Based Session #1 Arjun Nair, London/UK |
| 17:30 – 18:00 | Q&A Session |